Marico Q3 Review - Impressive Topline Growth, Likely To Sustain: Motilal Oswal
Marico Ltd. health and beauty products are displayed on the shelf of a department store in Mumbai, India. ( photographer Prashanth Vishwanathan/Bloomberg)

Marico Q3 Review - Impressive Topline Growth, Likely To Sustain: Motilal Oswal

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

Led by domestic volume growth of 15% (its highest in 34 quarters), Marico Ltd. exceeded expectations on the sales front, a trend that is likely to continue for the next few quarters, with all key segments doing well and a weak base in the next couple of quarters.

Strong momentum in key segments, increased confidence, and new launches in foods led us to forecast approximately 12% revenue compound annual growth rate between FY21- FY23E, much higher than the 5% CAGR witnessed over FY15-20.

At the same time, judicious price increases and expected reduction in commodity costs from current elevated levels would result in an improvement in operating margin, which were below expectations in Q3 FY21, going forward.

Click on the attachment to read the full report:

Motilal Oswal Marico Q3FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.